APVO icon

Aptevo Therapeutics

9 hedge funds and large institutions have $37.4M invested in Aptevo Therapeutics in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
+2
Holders Change %
+28.57%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Dimensional Fund Advisors
1
Dimensional Fund Advisors
Texas
$6.75M
Renaissance Technologies
2
Renaissance Technologies
New York
$5.74M +$1.91M +1 +50%
Vanguard Group
3
Vanguard Group
Pennsylvania
$3.66M
SC
4
Sessa Capital
New York
$2.59M -$7.78M -3 -75%
PWAM
5
Park West Asset Management
California
$2.5M +$2.5M +1 New
Acadian Asset Management
6
Acadian Asset Management
Massachusetts
$1.83M +$1.83M +1 New
BlackRock
7
BlackRock
New York
$1.75M
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
$1.58M
JPMorgan Chase & Co
9
JPMorgan Chase & Co
New York
$1.45M
HS
10
HighVista Strategies
Massachusetts
$981K
OAM
11
Oxford Asset Management
United Kingdom
$874K -$460K
SIM
12
Spark Investment Management
New York
$676K -$423K
CL
13
CSS LLC
Illinois
$592K -$647K
AIM
14
Alambic Investment Management
California
$581K -$646K
Geode Capital Management
15
Geode Capital Management
Massachusetts
$552K -$314K
EI
16
EAM Investors
California
$552K
BCM
17
Bridgeway Capital Management
Texas
$469K -$307K
Macquarie Group
18
Macquarie Group
Australia
$386K -$267K
Man Group
19
Man Group
United Kingdom
$380K -$63K
Deutsche Bank
20
Deutsche Bank
Germany
$363K
Northern Trust
21
Northern Trust
Illinois
$352K -$190K
Millennium Management
22
Millennium Management
New York
$318K -$317K
QI
23
QS Investors
New York
$315K -$207K
ACA
24
Atlas Capital Advisors
Wyoming
$232K -$143K
UBS Group
25
UBS Group
Switzerland
$189K -$149K